| 1 | Vertex Pharmaceuticals IncorporatedVRTX | $136.4B | $537.79 |
| 2 | Regeneron Pharmaceuticals, Inc.REGN | $98.5B | $952.40 |
| 3 | Moderna, Inc.MRNA | $87.1B | $215.27 |
| 4 | Revolution Medicines, Inc.RVMD | $36.1B | $166.87 |
| 5 | Roivant Sciences Ltd.ROIV | $28.0B | $38.61 |
| 6 | Insmed IncorporatedINSM | $27.0B | $122.88 |
| 7 | United Therapeutics CorporationUTHR | $25.0B | $587.88 |
| 8 | Incyte CorporationINCY | $24.5B | $120.27 |
| 9 | Alnylam Pharmaceuticals, Inc.ALNY | $21.4B | $159.73 |
| 10 | Exelixis, Inc.EXEL | $16.9B | $67.10 |
| 11 | Neurocrine Biosciences, Inc.NBIX | $16.7B | $165.31 |
| 12 | Jazz Pharmaceuticals plcJAZZ | $15.4B | $239.77 |
| 13 | BridgeBio Pharma, Inc.BBIO | $15.1B | $77.36 |
| 14 | Bio-Techne CorporationTECH | $11.4B | $72.79 |
| 15 | BioMarin Pharmaceutical Inc.BMRN | $11.2B | $57.99 |
| 16 | Halozyme Therapeutics, Inc.HALO | $11.0B | $96.50 |
| 17 | Kymera Therapeutics, Inc.KYMR | $10.7B | $125.85 |
| 18 | Madrigal Pharmaceuticals, Inc.MDGL | $9.8B | $423.96 |
| 19 | Vaxcyte, Inc.PCVX | $9.8B | $61.61 |
| 20 | TG Therapeutics, Inc.TGTX | $9.5B | $62.76 |
| 21 | Spyre Therapeutics, Inc.SYRE | $9.4B | $99.37 |
| 22 | Summit Therapeutics Inc.SMMT | $9.4B | $11.82 |
| 23 | Krystal Biotech, Inc.KRYS | $8.8B | $297.90 |
| 24 | Praxis Precision Medicines, Inc.PRAX | $8.7B | $310.27 |
| 25 | Apogee Therapeutics, Inc.APGE | $8.4B | $135.07 |
| 26 | Protagonist Therapeutics, Inc.PTGX | $8.1B | $124.83 |
| 27 | CG Oncology Inc.CGON | $7.6B | $84.78 |
| 28 | Rhythm Pharmaceuticals, Inc.RYTM | $7.5B | $107.48 |
| 29 | Cytokinetics, IncorporatedCYTK | $7.4B | $53.17 |
| 30 | Axsome Therapeutics, Inc.AXSM | $7.2B | $137.01 |
| 31 | Twist Bioscience CorporationTWST | $6.9B | $105.04 |
| 32 | Immunovant, Inc.IMVT | $6.9B | $33.28 |
| 33 | Oruka Therapeutics, Inc.ORKA | $6.7B | $99.24 |
| 34 | 10x Genomics, Inc.TXG | $6.7B | $54.99 |
| 35 | Kodiak Sciences Inc.KOD | $6.6B | $100.73 |
| 36 | ImmunityBio, Inc.IBRX | $6.4B | $5.98 |
| 37 | Arrowhead Pharmaceuticals, Inc.ARWR | $6.2B | $44.21 |
| 38 | Ligand Pharmaceuticals IncorporatedLGND | $6.0B | $301.71 |
| 39 | Caris Life Sciences, Inc.CAI | $6.0B | $21.00 |
| 40 | Mirum Pharmaceuticals, Inc.MIRM | $6.0B | $91.58 |
| 41 | Scholar Rock Holding CorporationSRRK | $5.4B | $44.54 |
| 42 | Veradermics, IncorporatedMANE | $5.4B | $128.05 |
| 43 | Erasca, Inc.ERAS | $5.3B | $15.11 |
| 44 | PTC Therapeutics, Inc.PTCT | $5.1B | $60.97 |
| 45 | Dianthus Therapeutics, Inc.DNTH | $5.0B | $89.55 |
| 46 | Cogent Biosciences, Inc.COGT | $4.8B | $27.44 |
| 47 | Travere Therapeutics, Inc.TVTX | $4.8B | $49.70 |
| 48 | Edgewise Therapeutics, Inc.EWTX | $4.7B | $43.68 |
| 49 | Ionis Pharmaceuticals, Inc.IONS | $4.7B | $28.01 |
| 50 | Adaptive Biotechnologies CorporationADPT | $4.5B | $27.87 |
| 51 | Definium Therapeutics, Inc.DFTX | $4.1B | $30.16 |
| 52 | Tango Therapeutics, Inc.TNGX | $4.1B | $24.17 |
| 53 | CRISPR Therapeutics AGCRSP | $3.9B | $40.37 |
| 54 | Tarsus Pharmaceuticals, Inc.TARS | $3.9B | $78.68 |
| 55 | Xenon Pharmaceuticals Inc.XENE | $3.9B | $39.26 |
| 56 | Relay Therapeutics, Inc.RLAY | $3.8B | $17.27 |
| 57 | Amylyx Pharmaceuticals, Inc.AMLX | $3.6B | $27.80 |
| 58 | Enliven Therapeutics, Inc.ELVN | $3.5B | $47.62 |
| 59 | Iovance Biotherapeutics, Inc.IOVA | $3.5B | $7.55 |
| 60 | Parabilis Medicines, Inc.PBLS | $3.5B | $28.45 |
| 61 | Arcutis Biotherapeutics, Inc.ARQT | $3.4B | $27.15 |
| 62 | Viking Therapeutics, Inc.VKTX | $3.4B | $26.80 |
| 63 | Viridian Therapeutics, Inc.VRDN | $3.4B | $29.80 |
| 64 | Acadia Pharmaceuticals Inc.ACAD | $3.2B | $18.67 |
| 65 | Dyne Therapeutics, Inc.DYN | $3.1B | $16.70 |
| 66 | Xeris Biopharma Holdings, Inc.XERS | $3.1B | $16.70 |
| 67 | ADMA Biologics, Inc.ADMA | $3.0B | $13.47 |
| 68 | Celcuity Inc.CELC | $3.0B | $60.57 |
| 69 | Disc Medicine, Inc.IRON | $2.9B | $76.59 |
| 70 | IDEAYA Biosciences, Inc.IDYA | $2.9B | $30.36 |
| 71 | Vericel CorporationVCEL | $2.9B | $57.48 |
| 72 | Denali Therapeutics Inc.DNLI | $2.9B | $18.08 |
| 73 | Xencor, Inc.XNCR | $2.7B | $35.40 |
| 74 | MBX Biosciences, Inc. Common StockMBX | $2.6B | $53.12 |
| 75 | Arcus Biosciences, Inc.RCUS | $2.4B | $16.86 |
| 76 | Celldex Therapeutics, Inc.CLDX | $2.2B | $28.59 |
| 77 | Beam Therapeutics Inc.BEAM | $2.2B | $20.94 |
| 78 | Alamar Biosciences, Inc.ALMR | $2.1B | $30.55 |
| 79 | Palvella Therapeutics, Inc.PVLA | $2.1B | $144.60 |
| 80 | Maravai LifeSciences Holdings, Inc.MRVI | $2.1B | $7.40 |
| 81 | Biohaven Ltd.BHVN | $2.1B | $13.80 |
| 82 | Immunome, Inc.IMNM | $2.1B | $17.61 |
| 83 | Aurinia Pharmaceuticals Inc.AUPH | $2.1B | $15.48 |
| 84 | Replimune Group, Inc.REPL | $2.0B | $21.41 |
| 85 | Septerna IncSEPN | $2.0B | $41.67 |
| 86 | First Tracks Biotherapeutics IncTRAX | $2.0B | $46.56 |
| 87 | Vera Therapeutics, Inc.VERA | $1.9B | $26.97 |
| 88 | Harmony Biosciences Holdings, Inc.HRMY | $1.9B | $32.96 |
| 89 | BioCryst Pharmaceuticals, Inc.BCRX | $1.9B | $7.45 |
| 90 | Trevi Therapeutics, Inc.TRVI | $1.9B | $13.29 |
| 91 | Zenas BioPharma, Inc.ZBIO | $1.9B | $27.93 |
| 92 | Fortrea Holdings Inc.FTRE | $1.9B | $19.79 |
| 93 | Maze Therapeutics, Inc.MAZE | $1.9B | $33.90 |
| 94 | Zymeworks Inc.ZYME | $1.8B | $26.45 |
| 95 | Hemab Therapeutics Holdings, Inc. Common StockCOAG | $1.8B | $39.06 |
| 96 | Recursion Pharmaceuticals, Inc.RXRX | $1.8B | $2.91 |
| 97 | Agios Pharmaceuticals, Inc.AGIO | $1.8B | $30.15 |
| 98 | Stoke Therapeutics, Inc.STOK | $1.7B | $26.63 |
| 99 | Vir Biotechnology, Inc.VIR | $1.6B | $9.58 |
| 100 | Kailera Therapeutics, Inc.KLRA | $1.6B | $12.57 |
| 101 | Sarepta Therapeutics, Inc.SRPT | $1.6B | $15.13 |
| 102 | Ultragenyx Pharmaceutical Inc.RARE | $1.6B | $15.90 |
| 103 | Nurix Therapeutics, Inc.NRIX | $1.6B | $14.73 |
| 104 | Precigen, Inc.PGEN | $1.5B | $4.30 |
| 105 | SELLAS Life Sciences Group, Inc.SLS | $1.5B | $7.47 |
| 106 | Damora Therapeutics, Inc.DMRA | $1.4B | $22.50 |
| 107 | LB Pharmaceuticals Inc Common StockLBRX | $1.4B | $42.99 |
| 108 | Intellia Therapeutics, Inc.NTLA | $1.4B | $9.86 |
| 109 | UroGen Pharma Ltd.URGN | $1.4B | $28.10 |
| 110 | Tyra Biosciences, Inc.TYRA | $1.4B | $19.74 |
| 111 | AnaptysBio, Inc.ANAB | $1.4B | $45.73 |
| 112 | Generate Biomedicines, Inc.GENB | $1.4B | $10.49 |
| 113 | Nuvation Bio Inc.NUVB | $1.4B | $3.84 |
| 114 | Novavax, Inc.NVAX | $1.3B | $8.06 |
| 115 | Avalyn Pharma Inc. Common StockAVLN | $1.3B | $29.76 |
| 116 | Ocular Therapeutix, Inc.OCUL | $1.3B | $6.01 |
| 117 | Taysha Gene Therapies, Inc.TSHA | $1.3B | $4.06 |
| 118 | Innoviva, Inc.INVA | $1.3B | $18.49 |
| 119 | Absci CorporationABSI | $1.3B | $7.48 |
| 120 | Mineralys Therapeutics, Inc.MLYS | $1.3B | $14.53 |
| 121 | MannKind CorporationMNKD | $1.3B | $3.96 |
| 122 | Omeros CorporationOMER | $1.2B | $16.68 |
| 123 | Rapport Therapeutics, Inc. Common StockRAPP | $1.2B | $24.82 |
| 124 | Kardigan, Inc.KARD | $1.1B | $12.85 |
| 125 | Inhibrx Biosciences Inc.INBX | $1.1B | $77.66 |
| 126 | Alto Neuroscience, Inc.ANRO | $1.1B | $27.12 |
| 127 | SpyGlass Pharma, Inc. Common StockSGP | $1.1B | $32.24 |
| 128 | Nektar TherapeuticsNKTR | $1.0B | $36.44 |
| 129 | Vor Biopharma Inc.VOR | $1.0B | $18.97 |
| 130 | Seaport Therapeutics, Inc. Common StockSPTX | $1.0B | $19.12 |
| 131 | Savara Inc.SVRA | $985.1M | $4.47 |
| 132 | Jade Biosciences, Inc.JBIO | $975.3M | $15.34 |
| 133 | Verastem, Inc.VSTM | $970.3M | $7.70 |
| 134 | Odyssey Therapeutics, Inc.ODTX | $930.6M | $19.36 |
| 135 | Corvus Pharmaceuticals, Inc.CRVS | $894.1M | $10.60 |
| 136 | Theravance Biopharma IncTBPH | $884.2M | $17.03 |
| 137 | Aktis Oncology, Inc.AKTS | $868.5M | $16.16 |
| 138 | MeiraGTx Holdings plcMGTX | $854.2M | $8.74 |
| 139 | Rigel Pharmaceuticals, Inc.RIGL | $823.4M | $43.73 |
| 140 | Syndax Pharmaceuticals, Inc.SNDX | $822.0M | $9.13 |
| 141 | Monte Rosa Therapeutics, Inc.GLUE | $782.7M | $9.16 |
| 142 | ORIC Pharmaceuticals, Inc.ORIC | $779.5M | $7.52 |
| 143 | Lexicon Pharmaceuticals, Inc.LXRX | $779.2M | $1.75 |
| 144 | Ardelyx, Inc.ARDX | $771.7M | $3.07 |
| 145 | Prime Medicine, Inc.PRME | $762.3M | $4.19 |
| 146 | Aura Biosciences, Inc.AURA | $751.4M | $7.22 |
| 147 | Solid Biosciences Inc.SLDB | $723.2M | $6.48 |
| 148 | OmniAb, Inc.OABI | $713.3M | $4.89 |
| 149 | Sagimet Biosciences Inc.SGMT | $712.6M | $10.13 |
| 150 | Achieve Life Sciences, Inc.ACHV | $697.7M | $6.78 |
| 151 | Annexon, Inc.ANNX | $681.0M | $3.57 |
| 152 | Apnimed, Inc.APMD | $677.7M | $16.28 |
| 153 | Janux Therapeutics, Inc.JANX | $668.1M | $10.92 |
| 154 | Alumis Inc.ALMS | $665.3M | $5.14 |
| 155 | Nuvectis Pharma, Inc.NVCT | $657.2M | $19.11 |
| 156 | Kura Oncology, Inc.KURA | $651.4M | $7.09 |
| 157 | Bicara Therapeutics Inc. Common StockBCAX | $647.3M | $9.75 |
| 158 | Olema Pharmaceuticals, Inc.OLMA | $644.8M | $7.36 |
| 159 | Design Therapeutics, Inc.DSGN | $635.2M | $9.92 |
| 160 | Immix Biopharma, Inc.IMMX | $626.9M | $7.48 |
| 161 | 4D Molecular Therapeutics, Inc.FDMT | $623.7M | $11.29 |
| 162 | Arbutus Biopharma CorpABUS | $619.3M | $4.04 |
| 163 | Cullinan Therapeutics, Inc.CGEM | $616.7M | $9.50 |
| 164 | Geron CorporationGERN | $606.8M | $0.94 |
| 165 | ArriVent BioPharma, Inc.AVBP | $597.9M | $11.56 |
| 166 | Climb Bio, Inc.CLYM | $583.9M | $9.94 |
| 167 | Aclaris Therapeutics, Inc.ACRS | $571.8M | $3.61 |
| 168 | Wave Life Sciences Ltd.WVE | $566.0M | $2.87 |
| 169 | Sana Biotechnology, Inc.SANA | $563.3M | $1.88 |
| 170 | Orchestra BioMed Holdings, Inc.OBIO | $560.4M | $7.12 |
| 171 | Ginkgo Bioworks Holdings, Inc.DNA | $551.0M | $8.50 |
| 172 | Zevra Therapeutics, Inc.ZVRA | $550.4M | $9.25 |
| 173 | Crescent Biopharma, Inc.CBIO | $525.1M | $13.50 |
| 174 | Monopar Therapeutics Inc.MNPR | $487.7M | $71.97 |
| 175 | REGENXBIO Inc.RGNX | $484.0M | $7.32 |
| 176 | Capricor Therapeutics, Inc.CAPR | $480.7M | $8.30 |
| 177 | Gyre Therapeutics, Inc.GYRE | $480.5M | $4.39 |
| 178 | Phathom Pharmaceuticals, Inc.PHAT | $478.0M | $5.88 |
| 179 | Shattuck Labs, Inc.STTK | $474.6M | $4.66 |
| 180 | MiMedx Group, Inc.MDXG | $464.0M | $3.18 |
| 181 | Candel Therapeutics, Inc.CADL | $455.8M | $5.81 |
| 182 | Ovid Therapeutics Inc.OVID | $453.0M | $2.40 |
| 183 | Fennec Pharmaceuticals Inc.FENC | $450.5M | $12.76 |
| 184 | Arvinas, Inc.ARVN | $443.3M | $6.77 |
| 185 | Assembly Biosciences, Inc.ASMB | $436.0M | $21.29 |
| 186 | CytomX Therapeutics, Inc.CTMX | $432.7M | $1.99 |
| 187 | Avalo Therapeutics, Inc.AVTX | $426.2M | $7.37 |
| 188 | Tectonic Therapeutic, Inc.TECX | $410.1M | $20.98 |
| 189 | Prothena Corporation plcPRTA | $409.3M | $7.97 |
| 190 | Opus Genetics, Inc.IRD | $390.5M | $4.04 |
| 191 | Relmada Therapeutics, Inc.RLMD | $385.2M | $3.61 |
| 192 | CorMedix Inc.CRMD | $383.4M | $4.82 |
| 193 | Alector, Inc.ALEC | $382.6M | $2.57 |
| 194 | Puma Biotechnology, Inc.PBYI | $379.5M | $7.34 |
| 195 | Neurogene Inc.NGNE | $368.2M | $23.30 |
| 196 | ARS Pharmaceuticals, Inc.SPRY | $360.9M | $3.59 |
| 197 | Lyell Immunopharma, Inc.LYEL | $360.2M | $14.65 |
| 198 | C4 Therapeutics, Inc.CCCC | $348.0M | $2.65 |
| 199 | Rezolute, Inc.RZLT | $346.3M | $3.58 |
| 200 | Contineum Therapeutics, Inc.CTNM | $341.9M | $9.67 |
| 201 | Atea Pharmaceuticals, Inc.AVIR | $330.9M | $4.12 |
| 202 | Larimar Therapeutics, Inc.LRMR | $311.6M | $3.00 |
| 203 | Enanta Pharmaceuticals, Inc.ENTA | $310.8M | $10.67 |
| 204 | Altimmune, Inc.ALT | $303.6M | $1.56 |
| 205 | Kyverna Therapeutics, Inc.KYTX | $300.9M | $4.76 |
| 206 | Benitec Biopharma Inc.BNTC | $298.0M | $8.54 |
| 207 | Century Therapeutics, Inc.IPSC | $297.8M | $1.64 |
| 208 | MapLight Therapeutics, Inc.MPLT | $294.1M | $6.90 |
| 209 | Evommune, Inc.EVMN | $293.6M | $7.10 |
| 210 | Eikon Therapeutics, Inc. Common StockEIKN | $291.5M | $5.39 |
| 211 | PepGen Inc.PEPG | $290.2M | $4.19 |
| 212 | X4 Pharmaceuticals, Inc.XFOR | $289.0M | $2.83 |
| 213 | Editas Medicine, Inc.EDIT | $288.6M | $1.87 |
| 214 | Agenus Inc.AGEN | $284.6M | $6.29 |
| 215 | Fulcrum Therapeutics, Inc.FULC | $283.4M | $3.71 |
| 216 | Allogene Therapeutics, Inc.ALLO | $279.6M | $0.81 |
| 217 | SAB Biotherapeutics, Inc.SABS | $270.3M | $3.00 |
| 218 | Nautilus Biotechnolgy, Inc.NAUT | $267.5M | $2.10 |
| 219 | Lexeo Therapeutics, Inc. Common StockLXEO | $265.1M | $3.23 |
| 220 | Ocugen, Inc.OCGN | $262.3M | $0.77 |
| 221 | Turn Therapeutics Inc.TTRX | $261.4M | $8.55 |
| 222 | Scribe Therapeutics Inc.SCTX | $248.7M | $15.37 |
| 223 | Q32 Bio Inc.QTTB | $248.1M | $8.29 |
| 224 | CAMP4 Therapeutics CorporationCAMP | $242.2M | $3.86 |
| 225 | Surrozen, Inc.SRZN | $241.7M | $32.32 |
| 226 | Rocket Pharmaceuticals, Inc.RCKT | $241.2M | $2.16 |
| 227 | BioAge Labs Inc.BIOA | $239.9M | $5.22 |
| 228 | Arcturus Therapeutics Holdings Inc.ARCT | $239.5M | $8.31 |
| 229 | Cabaletta Bio, Inc.CABA | $239.4M | $1.11 |
| 230 | Vanda Pharmaceuticals Inc.VNDA | $230.4M | $3.81 |
| 231 | Immuneering CorporationIMRX | $228.0M | $3.52 |
| 232 | Bright Minds Biosciences Inc.DRUG | $223.0M | $22.61 |
| 233 | Inhibikase Therapeutics, Inc.IKT | $203.4M | $1.45 |
| 234 | Precision BioSciences, Inc.DTIL | $203.4M | $7.28 |
| 235 | Greenwich LifeSciences, Inc.GLSI | $202.0M | $13.76 |
| 236 | Lineage Cell Therapeutics, Inc.LCTX | $201.1M | $0.80 |
| 237 | Galectin Therapeutics Inc.GALT | $198.9M | $3.02 |
| 238 | Prelude Therapeutics IncorporatedPRLD | $197.4M | $3.41 |
| 239 | Keros Therapeutics, Inc.KROS | $196.8M | $10.03 |
| 240 | Artiva Biotherapeutics, Inc.ARTV | $195.8M | $3.96 |
| 241 | Entrada Therapeutics, Inc.TRDA | $195.8M | $5.00 |
| 242 | Cartesian Therapeutics, Inc.RNAC | $185.5M | $6.08 |
| 243 | Korro Bio, Inc.KRRO | $183.3M | $12.71 |
| 244 | Whitehawk Therapeutics IncWHWK | $177.6M | $3.01 |
| 245 | MediWound Ltd.MDWD | $174.9M | $13.55 |
| 246 | AN2 Therapeutics, Inc.ANTX | $169.6M | $4.47 |
| 247 | Pyxis Oncology, Inc.PYXS | $168.6M | $1.41 |
| 248 | Eledon Pharmaceuticals, Inc.ELDN | $166.4M | $1.97 |
| 249 | ADC Therapeutics S.A.ADCT | $159.6M | $1.25 |
| 250 | Niagen Bioscience IncNAGE | $159.2M | $2.01 |
| 251 | BridgeBio Oncology Therapeutics Inc.BBOT | $158.9M | $1.98 |
| 252 | Invivyd, Inc.IVVD | $158.5M | $0.54 |
| 253 | Zentalis Pharmaceuticals, Inc.ZNTL | $157.2M | $1.60 |
| 254 | Sutro Biopharma, Inc.STRO | $154.7M | $9.32 |
| 255 | Humacyte, Inc.HUMA | $150.1M | $0.54 |
| 256 | Abeona Therapeutics Inc.ABEO | $148.6M | $2.60 |
| 257 | Protara Therapeutics, Inc.TARA | $146.5M | $2.38 |
| 258 | Sionna Therapeutics, Inc.SION | $141.1M | $3.12 |
| 259 | Atrium Therapeutics, Inc.RNA | $138.7M | $6.43 |
| 260 | MacroGenics, Inc.MGNX | $138.7M | $2.17 |
| 261 | ALX Oncology Holdings Inc.ALXO | $138.3M | $1.00 |
| 262 | Fate Therapeutics, Inc.FATE | $132.9M | $1.14 |
| 263 | Neonc Technologies Holdings, Inc.NTHI | $131.0M | $4.54 |
| 264 | Canton Strategic Holdings IncCNTN | $130.7M | $1.64 |
| 265 | Akebia Therapeutics, Inc.AKBA | $124.6M | $0.45 |
| 266 | MaxCyte, Inc.MXCT | $121.8M | $1.18 |
| 267 | Spruce Biosciences, Inc.SPRB | $121.4M | $42.25 |
| 268 | LENZ Therapeutics, Inc.LENZ | $120.0M | $3.82 |
| 269 | Compass Therapeutics, Inc.CMPX | $119.1M | $0.66 |
| 270 | Upstream Bio, Inc.UPB | $117.8M | $2.15 |
| 271 | Codexis, Inc.CDXS | $116.2M | $1.06 |
| 272 | OnKure Therapeutics, Inc.OKUR | $111.4M | $2.75 |
| 273 | Armata Pharmaceuticals, Inc.ARMP | $111.2M | $2.99 |
| 274 | Minerva Neurosciences, Inc.NERV | $109.6M | $2.20 |
| 275 | Foghorn Therapeutics Inc.FHTX | $107.3M | $1.79 |
| 276 | ImmuCell CorporationICCC | $103.8M | $11.42 |
| 277 | Cue Biopharma, Inc.CUE | $102.4M | $14.10 |
| 278 | Voyager Therapeutics, Inc.VYGR | $101.4M | $1.63 |
| 279 | Unicycive Therapeutics, Inc.UNCY | $101.4M | $3.70 |
| 280 | Immunic, Inc.IMUX | $98.6M | $7.23 |
| 281 | Inovio Pharmaceuticals, Inc.INO | $96.7M | $1.40 |
| 282 | Outlook Therapeutics, Inc.OTLK | $96.4M | $0.40 |
| 283 | NRx Pharmaceuticals, Inc.NRXP | $93.8M | $2.15 |
| 284 | Vivani Medical, Inc.VANI | $92.0M | $1.02 |
| 285 | Cibus, Inc.CBUS | $91.7M | $1.20 |
| 286 | PMV Pharmaceuticals, Inc.PMVP | $89.9M | $1.19 |
| 287 | Anixa Biosciences, Inc.ANIX | $88.6M | $2.55 |
| 288 | Black Diamond Therapeutics, Inc.BDTX | $87.9M | $1.53 |
| 289 | Genelux CorporationGNLX | $86.9M | $1.92 |
| 290 | Nkarta, Inc.NKTX | $86.7M | $1.21 |
| 291 | TuHURA Biosciences, Inc.HURA | $84.8M | $1.33 |
| 292 | Polaryx Therapeutics, Inc. Common StockPLYX | $83.2M | $1.67 |
| 293 | Rallybio CorporationRLYB | $83.0M | $15.43 |
| 294 | Seer, Inc.SEER | $82.6M | $1.48 |
| 295 | Coherus Oncology, Inc.CHRS | $78.2M | $0.51 |
| 296 | Tenaya Therapeutics, Inc.TNYA | $76.0M | $0.33 |
| 297 | Anavex Life Sciences Corp.AVXL | $75.8M | $0.82 |
| 298 | Equillium, Inc.EQ | $72.9M | $1.15 |
| 299 | Nutriband Inc.NTRB | $70.6M | $5.81 |
| 300 | Coya Therapeutics, Inc.COYA | $70.4M | $3.00 |
| 301 | vTv Therapeutics Inc.VTVT | $69.9M | $17.69 |
| 302 | Corbus Pharmaceuticals Holdings, Inc.CRBP | $69.5M | $3.38 |
| 303 | Neumora Therapeutics, Inc. Common StockNMRA | $69.4M | $0.37 |
| 304 | NeurAxis, Inc.NRXS | $68.1M | $4.80 |
| 305 | Tenax Therapeutics, Inc.TENX | $67.4M | $1.48 |
| 306 | Gossamer Bio, Inc.GOSS | $67.2M | $10.98 |
| 307 | Cardiff Oncology, Inc.CRDF | $65.9M | $0.85 |
| 308 | Atara Biotherapeutics, Inc.ATRA | $65.2M | $6.40 |
| 309 | Champions Oncology, Inc.CSBR | $65.1M | $4.68 |
| 310 | Acrivon Therapeutics, Inc. Common StockACRV | $62.6M | $1.46 |
| 311 | MAIA Biotechnology, Inc.MAIA | $62.4M | $1.01 |
| 312 | Cognition Therapeutics, Inc.CGTX | $60.8M | $0.64 |
| 313 | Fortress Biotech, Inc.FBIO | $57.0M | $1.71 |
| 314 | Boundless Bio, Inc.BOLD | $56.9M | $2.41 |
| 315 | Tonix Pharmaceuticals Holding Corp.TNXP | $56.0M | $2.88 |
| 316 | Spero Therapeutics, Inc.SPRO | $55.1M | $0.95 |
| 317 | Verrica Pharmaceuticals Inc.VRCA | $55.0M | $3.20 |
| 318 | Cingulate Inc.CING | $54.5M | $3.75 |
| 319 | Xilio Therapeutics, Inc.XLO | $54.4M | $7.70 |
| 320 | Heron Therapeutics, Inc.HRTX | $54.1M | $0.28 |
| 321 | MiNK Therapeutics, Inc.INKT | $48.0M | $9.35 |
| 322 | RenovoRx, Inc.RNXT | $46.1M | $0.95 |
| 323 | Eloxx Pharmaceuticals, Inc.ELOX | $43.8M | $12.75 |
| 324 | Pliant Therapeutics, Inc.PLRX | $43.0M | $0.69 |
| 325 | Aldeyra TheALDX | $40.4M | $0.67 |
| 326 | Instil Bio, Inc.TIL | $39.0M | $5.75 |
| 327 | Caribou Biosciences, Inc.CRBU | $38.1M | $0.35 |
| 328 | Biomea Fusion, Inc.BMEA | $37.8M | $0.52 |
| 329 | eXoZymes, Inc.EXOZ | $37.0M | $3.99 |
| 330 | ImageneBio IncIMA | $36.3M | $3.20 |
| 331 | Telomir Pharmaceuticals, Inc. Common StockTELO | $35.4M | $0.48 |
| 332 | Rani Therapeutics Holdings, Inc.RANI | $35.3M | $0.54 |
| 333 | Kalaris Therapeutics IncKLRS | $34.8M | $1.46 |
| 334 | Annovis Bio, Inc.ANVS | $32.0M | $0.75 |
| 335 | OS Therapies IncorporatedOSTX | $31.9M | $0.68 |
| 336 | INmune Bio, Inc.INMB | $29.3M | $0.95 |
| 337 | Pelthos Therapeutics Inc.PTHS | $28.1M | $7.15 |
| 338 | Aardvark Therapeutics, Inc. Common StockAARD | $27.6M | $1.26 |
| 339 | EyePoint Pharmaceuticals, Inc.EYPT | $25.8M | $0.31 |
| 340 | Adicet Bio, Inc.ACET | $25.7M | $2.75 |
| 341 | Acumen Pharmaceuticals, Inc.ABOS | $15.6M | $0.22 |
| 342 | Seres Therapeutics, Inc.MCRB | $14.4M | $1.41 |
| 343 | Fractyl Health, Inc.GUTS | $13.2M | $0.99 |